Trial on Reaxys Medicinal Chemistry

Release time:2018-06-26194

Information Page:

Access URL: 

Period of validity :  Jun. 22, 2018 - Aug. 21


Reaxys Medicinal Chemistry integration with Reaxys in the platform to empowers hit identification and lead optimization with normalized substance–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles. It combines the world’s largest and best-organized substance bioactivity data with tools for hitset assessment and the possibilities to export data to existing computational environments, facilitating harmonized analysis of in-house and external data. It covers over 35M bioactivity data point and 20k druggable target.